Browsing: MCTO

Vancouver, BC – NexOptic Technology Corp. (TSXV:NXO) announces its bi-weekly default status report as required under National Policy 12-203, confirming no material changes since its MCTO Notice on May 1, 2025.

BioVaxys Technology Corp. provides a bi-weekly update on the status of its Management Cease Trade Order (MCTO).

BioVaxys Technology Corp. (BIOV) has received a management cease trade order from the British Columbia Securities Commission following delays in its audited annual financial statements. The company expects to complete the filings by March 30, 2025.

BioVaxys Technology Corp. has received a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements.